BOSTON, Nov. 3, 2025 /PRNewswire/ -- Servier today announced longer-term data from the Phase 3 INDIGO trial evaluating VORANIGO ® (vorasidenib) versus placebo in patients with Grade 2 mutant ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...
For digital creators, the age-old dilemma persists: professional-grade drawing displays demand size and weight that make them impractical for desk use. At the same time, portable tablets often cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback